Palbociclib
From Proteopedia
| ||||||||||||
Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
| ||||||||||||
This page was last modified 10:16, 11 October 2023.